10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,834,064 | -6.4% | 92,947 | +26.7% | 0.48% | -14.2% |
| Q2 2023 | $4,097,874 | -0.1% | 73,386 | -0.1% | 0.56% | +1.4% |
| Q1 2023 | $4,100,286 | -0.2% | 73,495 | +166.5% | 0.56% | +77.6% |
| Q4 2021 | $4,107,000 | -21.2% | 27,573 | -23.0% | 0.31% | -16.3% |
| Q3 2021 | $5,212,000 | -7.9% | 35,800 | +23.9% | 0.37% | 0.0% |
| Q2 2021 | $5,659,000 | -13.6% | 28,900 | -20.2% | 0.37% | -20.6% |
| Q1 2021 | $6,552,000 | +9.1% | 36,200 | -14.6% | 0.47% | +16.0% |
| Q4 2020 | $6,004,000 | -26.5% | 42,401 | -35.3% | 0.41% | -24.7% |
| Q3 2020 | $8,169,000 | +13.1% | 65,522 | -19.0% | 0.54% | +9.6% |
| Q2 2020 | $7,225,000 | – | 80,900 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |